Nisamox Palatable Tablets 500mg
Nisamox Palatable Tablets 500mg
Authorised
- Amoxicillin trihydrate
- Potassium clavulanate
Product identification
Medicine name:
Nisamox Palatable Tablets 500mg
NISAMOX 400 mg /100 mg COMPRIMIDOS PARA PERROS
Active substance:
- Amoxicillin trihydrate
- Potassium clavulanate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Amoxicillin trihydrate400.00/milligram(s)1.00Tablet
-
Potassium clavulanate105.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Available in:
-
Spain
Package description:
- box containing 100 tablets (20 blister)
- box containing 25 tablets (5 blister)
- box containing 20 tablets (4 blister)
- box containing 10 tablets (2 blister)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Laboratories (Ireland) Limited
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 1864 ESP
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0346/001
Concerned member states:
-
Italy
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 23/03/2023
Spanish (PDF)
Published on: 4/12/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 4/12/2025
